Trial Holdings Inc. (JP:141A)
:141A
Want to see JP:141A full AI Analyst Report?
Top Page
Trial Holdings Inc.
(141A)
Select Model
Select Model
Rating:50Neutral
Price Target:
¥2,745.00
▼(-11.45% Downside)
Action:Reiterated
Date:05/20/26
The score is held back primarily by the sharp deterioration in 2025 cash flow despite positive earnings, which increases financing and execution risk. Technicals are also weak with the stock trading below key moving averages and negative MACD. High valuation (P/E ~69) with a low dividend yield provides limited support, partly offset by solid multi-year revenue growth and a generally reasonable leverage profile.
Positive Factors
Multi-year Revenue Growth
Sustained, multi-year top-line growth demonstrates durable demand for the company’s discount retail model and supports scale advantages. Over 2–6 months this trend indicates continued market penetration and a larger sales base that can underpin margin recovery and reinvestment.
Negative Factors
2025 Cash-flow Reversal
A sharp swing to negative operating and free cash flow materially weakens earnings quality and raises funding risk. If working-capital demands or capex persist, management may need external financing, constraining strategic options and increasing execution risk over the coming months.
Read all positive and negative factors
Positive Factors
Negative Factors
Multi-year Revenue Growth
Sustained, multi-year top-line growth demonstrates durable demand for the company’s discount retail model and supports scale advantages. Over 2–6 months this trend indicates continued market penetration and a larger sales base that can underpin margin recovery and reinvestment.
Read all positive factors
Trial Holdings Inc. (141A) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥337.22B
Dividend Yield0.56%
Average Volume (3M)1.03M
Price to Earnings (P/E)36.0
Beta (1Y)0.42
Revenue Growth55.84%
EPS Growth-10.10%
CountryJP
Employees6,529
SectorConsumer Defensive
Sector Strength42
IndustryDiscount Stores
Share Statistics
EPS (TTM)76.01
Shares Outstanding122,848,400
10 Day Avg. Volume1,438,280
30 Day Avg. Volume1,025,323
Financial Highlights & Ratios
PEG Ratio9.27
Price to Book (P/B)2.24
Price to Sales (P/S)0.35
P/FCF Ratio-7.35
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)22.43
Revenue Forecast (FY)¥1.34T
Trial Holdings Inc. Business Overview & Revenue Model
Company Description
Trial Holdings Inc. is a diversified enterprise actively engaged across several key sectors, including retail commerce, supply chain management, financial technology services, and specialized retail technology solutions. The company manages an ext...
How the Company Makes Money
null...
Trial Holdings Inc. Financial Statement Overview
Summary
Income Statement
72
Positive
Balance Sheet
74
Positive
Cash Flow
38
Negative
| Breakdown | TTM | Jun 2024 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.22T | 806.59B | 720.44B | 655.48B | 597.69B | 157.93B |
| Gross Profit | 294.99B | 155.13B | 134.00B | 117.53B | 103.49B | 26.32B |
| EBITDA | 62.76B | 33.73B | 30.78B | 25.03B | 21.58B | 5.42B |
| Net Income | 9.30B | 11.75B | 11.44B | 8.09B | 7.13B | 1.85B |
Balance Sheet | ||||||
| Total Assets | 784.94B | 300.28B | 283.63B | 200.64B | 185.73B | 171.44B |
| Cash, Cash Equivalents and Short-Term Investments | 60.47B | 72.33B | 91.95B | 23.90B | 27.43B | 22.74B |
| Total Debt | 392.13B | 38.56B | 16.16B | 19.61B | 24.44B | 27.94B |
| Total Liabilities | 650.77B | 171.25B | 165.44B | 132.62B | 126.02B | 118.65B |
| Stockholders Equity | 130.87B | 126.13B | 115.68B | 65.89B | 57.96B | 51.47B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -38.41B | 36.90B | 2.55B | 10.01B | -7.10B |
| Operating Cash Flow | 0.00 | -4.45B | 59.50B | 18.45B | 22.34B | -2.94B |
| Investing Cash Flow | 0.00 | -35.89B | -26.00B | -16.77B | -13.49B | -4.72B |
| Financing Cash Flow | 0.00 | 20.77B | 34.50B | -5.19B | -4.32B | -1.34B |
Trial Holdings Inc. Technical Analysis
Negative
3100.00
Price Trends
3556.40
Negative
3702.64
Negative
3100.53
Negative
Market Momentum
-202.12
Negative
38.52
Neutral
23.17
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:141A, the sentiment is Negative. The current price of 3100 is above the 20-day moving average (MA) of 2778.40, below the 50-day MA of 3556.40, and below the 200-day MA of 3100.53, indicating a bearish trend. The MACD of -202.12 indicates Negative momentum. The RSI at 38.52 is Neutral, neither overbought nor oversold. The STOCH value of 23.17 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:141A.
Trial Holdings Inc. Peers Comparison
UnderperformOutperform
Sector (62)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥101.04B | 9.97 | ― | 1.92% | 2.00% | 9.17% | |
69 Neutral | ¥218.46B | 23.19 | ― | 2.43% | 3.62% | 11.00% | |
69 Neutral | ¥128.75B | 10.30 | ― | 1.64% | 9.19% | 2.45% | |
68 Neutral | ¥313.98B | 8.35 | 4.97% | 2.01% | -0.23% | -16.92% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
61 Neutral | ¥2.57T | 22.67 | 16.37% | 0.73% | 7.63% | 17.33% | |
50 Neutral | ¥337.22B | 35.97 | ― | 0.56% | 55.84% | -10.10% |
* Consumer Defensive Sector Average
JP:141A
Trial Holdings Inc.
2,745.00
563.08
25.81%
JP:7532
Pan Pacific International Holdings
819.00
-134.68
-14.12%
JP:8242
H2O Retailing Corporation
2,574.00
696.92
37.13%
JP:8194
Life Corporation
2,525.00
393.91
18.48%
JP:8198
Maxvalu Tokai Co., Ltd.
3,175.00
-11.79
-0.37%
JP:9974
BELC Co., Ltd.
6,170.00
-1,051.82
-14.56%
Trial Holdings Inc. Corporate Events
TRIAL Holdings Posts Robust May Sales as Store Expansion Bolsters Growth
Jun 10, 2026
TRIAL Holdings reported strong same-store sales in May of its FY6/2026, with same-store sales up 7.2% year-on-year, driven by a 2.0% rise in customer traffic and higher average spending amid favorable weather and additional holidays. Seasonal summ...
TRIAL Holdings Posts Surging Sales but Slashes Full-Year Profit Outlook
May 14, 2026
TRIAL Holdings reported a sharp rise in nine-month net sales to ¥1.00 trillion, up 67.3% year on year, with EBITDA more than doubling and operating profit jumping 70.4%, reflecting strong top-line momentum after consolidation effects and expa...
Trial Holdings Lifts Full-Year Profit Outlook on Strong Sales, Keeps Net Income View
May 14, 2026
Trial Holdings has raised its full-year consolidated forecast for the fiscal year ending June 30, 2026, citing stronger-than-expected net sales and improved cost control. The company now expects higher net sales, EBITDA, operating profit and ordin...
TRIAL Holdings lifts same-store sales above plan as it reshapes store network
May 11, 2026
TRIAL Holdings reported that same-store sales growth for the first ten months of FY6/2026 reached 101.7%, surpassing its full-year plan, supported by higher average spending despite softer customer traffic. Overall sales remained strong across foo...
TRIAL Holdings Lifts Sales and Membership on SU-PAY Promotion and Store Expansion
Apr 10, 2026
TRIAL Holdings reported steady year-on-year sales growth across its store network in early 2026, supported by favorable spring weather and strong customer response to its SU-PAY Festival promotional campaign. The event, which replaced the annual T...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.